An evaluation of efficacy and safety of reboxetine in elderly patients affected by “retarded” post-stroke depression: A random, placebo-controlled study
- 30 June 2005
- journal article
- clinical trial
- Published by Elsevier BV in Archives of Gerontology and Geriatrics
- Vol. 40 (3), 275-285
- https://doi.org/10.1016/j.archger.2004.09.004
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Research into the specificity of depression after stroke: a review on an unresolved issueProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2001
- Vascular depression: new light on an established idea?Journal of Neurology, Neurosurgery & Psychiatry, 2001
- Pharmacokinetics of reboxetine in healthy, elderly volunteers.European Journal of Drug Metabolism and Pharmacokinetics, 2000
- Reboxetine in the maintenance therapy of depressive disorder in the elderly: a long-term open studyInternational Journal of Geriatric Psychiatry, 2000
- Treatment of Poststroke DepressionJAMA, 2000
- Reboxetine in the treatment of depression in the elderly: pilot study.Journal of Geriatric Psychiatry and Neurology, 1999
- Clinical efficacy of reboxetine: a comparative study with desipramine, with methodological considerationsHuman Psychopharmacology: Clinical and Experimental, 1998
- Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive episodesEuropean Neuropsychopharmacology, 1997
- Risk factors for post‐stroke depressionActa Psychiatrica Scandinavica, 1995
- Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram.Stroke, 1994